Structural Insights into the Mechanism of GTPase Activation in the GIMAP Family  by Schwefel, David et al.
Structure
ArticleStructural Insights into the Mechanism
of GTPase Activation in the GIMAP Family
DavidSchwefel,1,2,7,*B.SivanandamArasu,1,2,6StephenF.Marino,1,6Bjo¨rn Lamprecht,1,3KarlKo¨chert,1 EvaRosenbaum,1
Jenny Eichhorst,4 Burkhard Wiesner,4 Joachim Behlke,1 Oliver Rocks,1 Stephan Mathas,1,3 and Oliver Daumke1,5,*
1Max-Delbru¨ck-Centrum fu¨r Molekulare Medizin, Robert-Ro¨ssle-Strasse 10, 13125 Berlin, Germany
2Institut fu¨r Chemie und Biochemie, Freie Universita¨t Berlin, Takustrasse 3, 14195 Berlin, Germany
3Hematology, Oncology and Tumorimmunology, Charite´-Universita¨tsmedizin Berlin, CVK, Augustenburger Platz 1, 13353 Berlin, Germany
4Leibniz-Institut fu¨r Molekulare Pharmakologie, Robert-Ro¨ssle-Str. 10, 13125 Berlin, Germany
5Institut fu¨r Medizinische Physik und Biophysik, Charite´, Ziegelstrasse 5-9, 10117 Berlin, Germany
6These authors contributed equally to this work
7Present address: MRC National Institute for Medical Research, The Ridgeway, Mill Hill, London NW71AA, UK
*Correspondence: david.schwefel@nimr.mrc.ac.uk (D.S.), oliver.daumke@mdc-berlin.de (O.D.)
http://dx.doi.org/10.1016/j.str.2013.01.014SUMMARY
GTPases of immunity-associated proteins (GIMAPs)
are regulators of lymphocyte survival and homeo-
stasis. We previously determined the structural basis
of GTP-dependent GIMAP2 scaffold formation on
lipid droplets. To understand how its GTP hydrolysis
is activated, we screened for other GIMAPs on
lipid droplets and identified GIMAP7. In contrast to
GIMAP2, GIMAP7 displayed dimerization-stimulated
GTP hydrolysis. The crystal structure of GTP-bound
GIMAP7 showed a homodimer that assembled via
the G domains, with the helical extensions protruding
in opposite directions. We identified a catalytic argi-
nine that is supplied to the opposing monomer to
stimulate GTP hydrolysis. GIMAP7 also stimulated
GTP hydrolysis by GIMAP2 via an analogous mecha-
nism. Finally, we foundGIMAP2 andGIMAP7 expres-
sion differentially regulated in several human T cell
lymphoma lines. Our findings suggest that GTPase
activity in the GIMAP family is controlled by homo-
and heterodimerization. This may have implications
for the differential roles of some GIMAPs in lympho-
cyte survival.
INTRODUCTION
GTPases of the immunity-associated proteins (GIMAPs) com-
prise a family of septin-related guanine nucleotide-binding (G)
proteins which are present in vertebrates, plants and some
viruses (reviewed in Nitta and Takahama, 2007). In vertebrates,
Gimap genes are grouped in chromosomal clusters and are
abundantly expressed in cells of the immune system (Poirier
et al., 1999; Kru¨cken et al., 2004). Animal models have demon-
strated an essential role for GIMAPs in the development and
maintenance of lymphocytes. The BioBreeding rat, with a frame-
shift mutation inGimap5, as well asGimap5 knockoutmice show
a severe reduction in the number of peripheral T cells (MacMur-
ray et al., 2002; Hornum et al., 2002; Michalkiewicz et al., 2004;550 Structure 21, 550–559, April 2, 2013 ª2013 Elsevier Ltd All rightsSchulteis et al., 2008). BioBreeding rats develop autoimmune
type 1 diabetes (T1D), whereas Gimap5 knockout mice die 12–
15 weeks after birth, likely due to immuno-inflammatory colitis
(Barnes et al., 2010). Disturbed development and increased
apoptosis rates are also observed in Gimap5-deficient hemato-
poietic stem and progenitor cells (Chen et al., 2011). Conditional
knockout of Gimap1 in mouse lymphoid tissues leads to
a dramatic loss of peripheral T and B cells, extending the impor-
tance of the GIMAP family also to the B cell lineage (Saunders
et al., 2010). In contrast, knockout of Gimap4 in mice has no
apparent effect on lymphocyte numbers (Schnell et al., 2006).
Furthermore, lymphocytes isolated from Gimap4 knockout
mice or from a rat strain with reduced Gimap4 expression
show increased resistance to apoptotic stimuli, suggesting
a pro-apoptotic function of GIMAP4 (Schnell et al., 2006; Carter
et al., 2007). GIMAPs are also implicated in human diseases.
Polymorphisms in the polyadenylation signal of GIMAP5 were
observed in patients with systemic lupus erythematosus (Hell-
quist et al., 2007). In regulatory T cells of patients with T1D,
several GIMAP genes are downregulated compared to those
of healthy individuals (Jailwala et al., 2009). Together with the
finding that GIMAP3, GIMAP4, and GIMAP5 interact with pro-
and anti-apoptotic members of the Bcl-2 family (Nitta et al.,
2006; Chen et al., 2011), these data suggest that GIMAPs control
the survival of lymphocytes by regulating apoptosis.
The seven human GIMAPs have molecular masses from 33 to
75 kDa. They are composed of an N-terminal G domain, followed
by C-terminal extensions of 60–130 amino acids (Dion et al.,
2005). As an exception, GIMAP8 consists of three such consec-
utive modules in one polypeptide. GIMAP1 and GIMAP5 each
contain a single C-terminal transmembrane helix, which anchors
them to the Golgi and the lysosomal compartments, respectively
(Wong et al., 2010). Two C-terminal hydrophobic sequence
stretches target human GIMAP2 to lipid droplets (Schwefel
et al., 2010b). These hydrophobic sequences are not found in
any mouse or rat GIMAP member.
Structural studies of GIMAP2 as a prototypic member of the
membrane-anchored GIMAPs showed that the G domain has
a canonical fold that phylogenetically relates them to the septin
and dynamin GTPases (Schwefel et al., 2010b). GTP binding
was proposed to induce assembly of GIMAP2 into a linear scaf-
fold via two distinct interfaces, the G-interface across thereserved
Figure 1. GIMAP2 andGIMAP7Colocalize at
the Surface of Lipid Droplets
(A) Localization of N-terminally mCherry-tagged
GIMAP7 (red) in living Jurkat cells. Lipid droplets
were costained with BODIPY 493/503 (green). All
scale bars represent 10 mm.
(B) The localization of endogenous GIMAP2 (red) in
Jurkat cells was determined by antibody staining
and immunofluorescence analysis. Lipid droplets
were costained with BODIPY 493/503 (green).
(C) N-terminally EGFP-tagged GIMAP7 (green) and
N-terminally mCherry-tagged GIMAP2 (red) were
coexpressed and visualized in living Jurkat cells.
See also Figure S1.
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GTPase Activation in the GIMAP Familynucleotide-binding site and the C-interface at the backside of the
G domain. The scaffold would be intrinsically stable because GI-
MAP2 was found not to hydrolyze GTP on its own.
In the present work, we followed up on our recent study to
identify regulators of the GIMAP2 scaffold that can stimulate its
GTPase activity and found GIMAP7 colocalizing with GIMAP2
on lipid droplets. We demonstrate that GIMAP7 can stimulate
both its own GTPase activity and that of GIMAP2 by dimerization
and the provision of a catalytic arginine finger. These findings
may have important implications for understanding the molec-
ular mechanisms by which GIMAPs regulate apoptosis.
RESULTS
GIMAP2 and GIMAP7 Colocalize on the Surface of Lipid
Droplets
GIMAPs are related to the septin and dynamin GTPases (Schwe-
fel et al., 2010b) that often show assembly-stimulated GTP
hydrolysis (Gasper et al., 2009). We hypothesized that other
GIMAP members might associate with GIMAP2 to activate its
GTPase function. To probe for such partners, we conducted
a subcellular localization screen for all human GIMAPs in
the human Jurkat T cell leukemia cell line using N-terminal
EGFP-GIMAP fusion proteins (Figure 1; Figure S1A available
online). EGFP-GIMAP1 was found in a speckled pattern in the
cytosol (Figure S1A), resembling the distribution of endogenous
mouse GIMAP1 at the Golgi apparatus (Wong et al., 2010). No
localization to lipid droplets was observed (Figure S1B). EGFP-
GIMAP5 localized to intracellular vesicles of varying size (Fig-
ure S1A), in agreement with the previously described localization
of endogenous mouse GIMAP5 to lysosomes (Wong et al.,Structure 21, 550–559, April 2, 20132010). In approximately 10% of trans-
fected cells, EGFP-GIMAP5 was addi-
tionally found at the plasma membrane
(e.g., Figure S1A), but no localization to
lipid droplets was observed (Figure S1B).
EGFP-GIMAP4, EGFP-GIMAP6, and
EGFP-GIMAP8were distributed uniformly
in the cytosol (Figure S1A). Strikingly,
EGFP-GIMAP7 was found on the surface
of spherical structures, resembling the
staining obtained with EGFP-GIMAP2
(Figures 1A and S1A). We confirmed
this localization to intracellular lipid drop-lets by costaining cells expressing mCherry-tagged GIMAP7
as well as endogenous GIMAP2 with the lipid droplet marker
BODIPY 493/503 (Figures 1A and 1B). Upon coexpression of
fluorescently-tagged GIMAP2 and GIMAP7, GIMAP7 fluores-
cence, while still localized to lipid droplets, was more diffuse,
suggesting that GIMAP2 competes with GIMAP7 for common
binding sites (Figure 1C).
Because GIMAP7 does not have a transmembrane anchor, we
wondered whether it might be dynamically recruited to lipid
droplets. We therefore analyzed the localization of mCherry-
GIMAP7 in response to an apoptotic stimulus (anti-CD95,
Figure S1C) or a stimulus inducing autophagy (suberoylanilide
hydroxamic acid [SAHA]; Figure S1D). Neither of these stimuli
markedly changed the localization of mCherry-GIMAP7. The
lack of a specific antibody prevented us from determining the
localization of endogenous GIMAP7 in Jurkat cells.
We previously showed that ectopic expression of GIMAP2
leads to a doubling of lipid droplet numbers (Schwefel et al.,
2010b). In contrast, ectopic expression of GIMAP7 did not signif-
icantly influence lipid droplet numbers (Figure S1E).
GIMAP7 Shows Dimerization-Dependent GTP
Hydrolysis
We then conducted a biochemical and structural analysis of
GIMAP7. GIMAP7was expressed as aGST-fusion inEscherichia
coli and purified to homogeneity (Figures S2A and S2B).
Because protein yields were low, we sought to improve the solu-
bility of GIMAP7 by mutating a putative surface-exposed hydro-
phobic residue, Leu100, to glutamine (L100Q). Indeed, this re-
sulted in a 10-fold increase in protein yields (Figure S2B). In the
absence of nucleotide, this mutant was monomeric, as wasª2013 Elsevier Ltd All rights reserved 551
Figure 2. Biochemical Characterization of GIMAP7
(A) Nucleotide-binding affinities for GIMAP7 L100Q were determined using
ITC. The following values were obtained from the fits: GIMAP7-GTP-g-S (,):
Kd = 10 ± 2 mM (n = 0.9), GIMAP7-GDP (B): Kd = 32 ± 2 mM (n = 0.8).
(B) Equilibrium sedimentation analytical ultracentrifugation experiments were
performed to determine apparent molecular masses at the indicated GIMAP7
concentrations; 200 mM GMPPNP (-) or 500 mM GDP (B) were added to
saturate GIMAP7 with the respective nucleotide. Monomer-dimer equilibria
were fitted to the data obtained in the presence of GDP (Kd = 110 ± 20 mM) and
GMPPNP (Kd = 9 ± 1 mM). Dashed lines indicate the molecular mass of the
GIMAP7 monomer and dimer.
(C) Single turnover GTP hydrolysis reactions for GIMAP7 (-) were performed
at 20C, using a nucleotide and protein concentration of 50 mM. Plotted is the
remaining GTP concentration versus time, determined as [GTP]/([GDP]+
[GTP])3[GTP]initial. Data points represent mean value ± SD of three indepen-
dent experiments. An exponential decay was fitted to the data. For compar-
ison, data of the cytosolic domain of GIMAP2 (residues 1–260,-) are shown.
(D) Initial observed rates frommultiple turnover GTP hydrolysis reactions in the
presence of 500 mM GTP (B) were determined for GIMAP7 at the indicated
protein concentrations (at least two independent measurements per data
point). Data were fitted to a monomer-dimer equilibrium (Praefcke et al., 1999).
A kmax value of 3.2 ± 0.2 min
1 and a Kd value of 1.2 ± 0.4 mM were obtained
from the fit.
See also Figure S2.
Table 1. GIMAP7 Data Collection and Refinement Statistics
Protein GIMAP7
Nucleotide GMPPNP
Data collection
Space group P1
Cell dimensions
a, b, c (A˚) 45.9, 90.9, 114.7
a, b, g () 77.3, 85.2, 89.2
Resolution (A˚) 35–3.09 (3.28–3.09)a
Rmerge (%) 10.9 (48.6)
I/s (I) 7.24 (1.58)
Completeness (%) 95.3 (93.2)
Redundancy 1.8 (1.83)
Refinement
Resolution (A˚) 32.44–3.15
No. reflections 29758
Rwork/Rfree 23.4/30.5
No. atoms
Protein 12423
Ligand/ion 198
Water 2
B-factors
Protein 72.4
Ligand/ion 89.1
Water 52.5
Rmsds
Bond lengths (A˚) 0.004
Bond angles () 0.921
aValues in parentheses are for highest-resolution shell.
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GTPase Activation in the GIMAP FamilyGIMAP7 wild-type, and also showed similar nucleotide hydro-
lysis properties (Figures S2C and S2D). Accordingly, all experi-
ments requiring large amounts of purified protein, such as
isothermal titration calorimetry (ITC) and crystallography, were
carried out with the GIMAP7 L100Q mutant.
Nucleotide-binding affinities for GIMAP7 L100Q were deter-
mined by ITC. It bound the nonhydrolyzable GTP analog,
guanosine 50-O-[gamma-thio]triphosphate (GTP-g-S), with an
equilibrium dissociation constant (Kd) of 10 mM, and GDP with
a Kd of 32 mM, in exothermic reactions (Figure 2A). These affini-
ties are approximately 250-fold lower than the corresponding
nucleotide affinities of GIMAP2. In analytical ultracentrifugation
experiments, a monomer-dimer equilibrium with a Kd of 9 mM
was observed in the presence of the nonhydrolyzable GTP
analog guanosine 50-[b,g-imido]triphosphate (GMPPNP) (Fig-
ure 2B)—a 25-fold higher affinity for self-association than in552 Structure 21, 550–559, April 2, 2013 ª2013 Elsevier Ltd All rightsthe case of GIMAP2. GIMAP7 also dimerized in the presence
of GDP, with a Kd of 100 mM (Figure 2B). In single turnover assays
monitoring one cycle of GTP hydrolysis, GIMAP7 efficiently
hydrolyzed GTP (Figure 2C). In multiple turnover assays (excess
of GTP over protein), GIMAP7 showed a protein concentration-
dependent increase in its specific GTPase activity with a kmax
of 3.2 min1 and an apparent Kd of 1.2 mM (Figure 2D), indicating
that the GTPase reaction of GIMAP7 is stimulated by a coopera-
tive mechanism.
Structure of GIMAP7
To obtain structural insights into catalysis, we crystallized
GIMAP7 L100Q in the presence of GMPPNP. Crystals diffracted
to a maximal resolution of 3.1 A˚. The model was refined to an
Rwork of 23.4% and an Rfree of 30.5% (Table 1; Figure S3A).
The asymmetric unit of the crystals contained six copies of
GIMAP7 (chains A–F); the best resolved chains, A and B, are
described in the following. Clear electron density for the
GMPPNP molecules was visible in the nucleotide-binding sites
of all six GIMAP7 monomers (Figure S3B).
The N-terminal six residues of GIMAP7 were disordered. Resi-
dues 7–196 form a Ras-like G domain with the GIMAP-specific
helix a3* inserted between strand b5 and helix a4 (Figures 3A
and 3B). The overall structure of the G domains of GIMAP7reserved
Figure 3. Structure of GIMAP7
(A) Schematic representation of the domain structure of GIMAP7 and GIMAP2
with amino acid positions indicated. HS, hydrophobic segment.
(B) Cartoon representation of the GMPPNP-bound GIMAP7 L100Q monomer.
The G domain is shown in green, switch I and switch II in blue, the P loop in red,
and the conserved box in cyan. Secondary structure elements differing from
the coreG domain of H-Ras (helix a3* and theC-terminal helices a6 and a7) are
shown in orange. The nucleotide is shown in ball-and-stick representation.
(C) Detailed view of the C-terminal extension and its contact to switch II and the
G domain. Selected residues are shown in stick representation.
(D) Comparison of the C-terminal extensions of GIMAP7 L100Q (orange) and
GIMAP2 (magenta). The G domain of GIMAP7 is colored green and super-
imposed on the GIMAP2 G domain (magenta). The solvent-accessible surface
of the GIMAP7 G domain is rendered semitransparent.
See also Figure S3.
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GTPase Activation in the GIMAP Familyand GIMAP2 can be superimposed with a root mean square
deviation (rmsd) of 1.3 A˚ along 194 aligned residues. The most
notable difference was observed in the partially disordered
switch II region, where Gly66 of GIMAP7 is stabilized by a back-
bone interaction with the GMPPNP g-phosphate, in contrast toStructure 21the corresponding Asp80 of GIMAP2, which is displaced
by the g-phosphate of GTP (Figure S3C). We previously
suggested a function of switch II in GIMAP2 in regulating the
release of helix a7 from the G domain. The divergent architec-
tures might indicate a different function of switch II in GIMAP7.
In the absence of stabilizing crystal contacts, the C-terminal
extension is partially disordered in five of the six GIMAP7 mono-
mers in the asymmetric unit (Figure S4A). In chain A, however, it
folds into two elongated helices, a6 and a7 (Figure 3B). Half of
the amino acids in this 90 residue helical domain are charged
and project toward the solvent. A multiple sequence alignment
shows that the closely related GIMAP4 has a similar charged
sequence stretch in this region (Figure S3A). The C-terminal
end of helix a7 folds against a hydrophobic patch of the G
domain created by the switch II region and helix a3 (Figure 3C).
A superposition of the G domains of GIMAP7 and GIMAP2
allowed for a direct comparison of their C-terminal extensions
(Figure 3D). Helix a6 and a7 in GIMAP7 are greatly extended
in length compared to those in GIMAP2. The short helix a6
from GIMAP2 is equivalent to the beginning of helix a6 in
GIMAP7. The flexible linker between a6 and a7 in GIMAP2 is
replaced by the extended helical region of GIMAP7. The
C-terminal end of helix a7 in GIMAP7 projects along the
G domain with a tilt of approximately 25 compared to the
corresponding region of GIMAP2. Helix a6 and a7 in GIMAP7
also form a larger interface with the G domain compared to
GIMAP2 (1100 A˚2 compared to 840 A˚2). These differences
suggest that the C-terminal extension of GIMAP7 is more tightly
associated to its G domain than that in GIMAP2 and probably
remains attached during the GTPase cycle, in contrast to the
proposed displacement of a7 in GIMAP2 upon GTP binding
(Schwefel et al., 2010b).
Structure of the Catalytically Active GIMAP7 Dimer
The six GIMAP7 monomers in the crystal structure were
arranged in three almost identical dimers (rmsd = 0.6–0.8 A˚ for
450–500 aligned residues per dimer; Figures 4A, 4B, and S4A).
Analogous to GIMAP2, switch I was stabilized by a contact of
Thr44 with the g-phosphate of the nucleotide. In turn, residues
in switch I (e.g., Ile38, Ala40) contacted helix a3* of the opposing
monomer, explaining the GTP-dependence of dimerization
(Figures 4C and S3A). Conserved box residue Glu106, along
with the adjacent Lys110, form a symmetric double salt bridge
across the dimer interface; additionally, Gln100, introduced by
the L100Q mutation, forms a double hydrogen bond with the
symmetry-related amino acid of the opposing molecule (Fig-
ure S4B). As in GIMAP2, Glu135 in the G4 motif binds to the
guanine base in cis, whereas the following Glu136 contacts the
guanine base of the opposing molecule in trans (Figure 4C).
The GIMAP7 dimer interface is composed of the conserved
box, switch I, the G4 loop and helix a3* (Figures 4B and 4C). It
shows a much larger buried surface area of 1500 A˚2 as
compared to the 600 A˚2 of the corresponding GIMAP2 dimer.
This is in line with the lower equilibrium dissociation constant
of the GIMAP7 dimer determined in solution (Figure 2B).
However, the principle assembly mode of GIMAPs via the
G-interface appears to be conserved.
The conserved box residue Arg117 in GIMAP2 is crucial for
dimerization by forming a hydrogen bond to Gln114 (Schwefel, 550–559, April 2, 2013 ª2013 Elsevier Ltd All rights reserved 553
Figure 4. The G-Interface Dimer of GIMAP7
(A) Cartoon representation of the GIMAP7 L100Q
dimer, with one protomer shown in the same
colors as in Figure 3B and the other protomer
shown in cyan/orange. The pseudo 2-fold dimer
axis is indicated by a dashed line.
(B) Superposition of the GIMAP7 L100Q (green)
and GIMAP2 (magenta, Protein Data Bank code
2XTN) G-domain dimers. The pseudo 2-fold dimer
axis is indicated by an ellipse.
(C) Detailed view of the GIMAP7 dimer interface.
To the right, a 180 rotation is shown. Selected
residues are shown in stick representation.
See also Figure S4.
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GTPase Activation in the GIMAP Familyet al., 2010b). The corresponding Arg103 in GIMAP7 is disor-
dered in five of the six GIMAP7 chains within the asymmetric
unit. Only in chain B is interpretable electron density for Arg103
apparent, showing that the residue forms water-mediated
hydrogen bonds to the nitrogen between the b- and g-phosphate
of GMPPNP in the opposing protomer (Figure 5A). In this orien-
tation, the arginine would be ideally situated to act as a catalytic
residue in the opposing molecule by counteracting the devel-
oping negative charge during GTP hydrolysis.
To characterize the catalytic mechanism of GIMAP7,
mutagenesis studies were performed (Figures 5B–5D). Glu136
in the center of the G-interface was mutated to the more bulky
tryptophan to interfere with dimerization. The E136W mutation
did not affect the binding affinity for GTP-g-S, as determined
by ITC measurement, but it did, surprisingly, result in an
endothermic binding reaction (Figure 5B). Indeed, it reduced
GTP-promoted dimerization (Figure 5C) and almost completely
abolished the GTPase reaction (Figure 5D), indicating that
dimerization via the G-interface is required for the stimulated
GTPase activity.554 Structure 21, 550–559, April 2, 2013 ª2013 Elsevier Ltd All rights reservedA mutation of the proposed catalytic
residue, Arg103, to aspartate also did
not interfere with the affinity for GTP-g-S
(Figure 5B). In contrast to the E136W
mutation, the R103D mutation did not
influence GTP-dependent dimerization
(Figure 5C). This is in agreement with the
observation that Arg103 is mostly disor-
dered in the GIMAP7 homodimers and
apparently not involved in dimerization.
The mutation did, however, completely
block the GTPase activity (Figure 5D).
These features are hallmarks of a catalytic
residue and indicate that Arg103 in
GIMAP7 acts as a catalytic arginine finger
in trans that is inserted into the catalytic
machinery of the opposing molecule
during the GTPase reaction.
GIMAP7 Stimulates GTP Hydrolysis
of GIMAP2
Considering our colocalization results, we
next asked whether GIMAP7 also stimu-
lates the GTPase reaction of GIMAP2 viaa similar mechanism involving heterodimerization. As previously
reported, the cytosolic domain of GIMAP2 (residues 1–260, used
in all experiments below) on its own displayed noGTPase activity
(Schwefel et al., 2010b). However, addition of 5 mM GIMAP7 to
50 mM GIMAP2 using single turnover conditions for GIMAP2
increased overall GTP hydrolysis in this mixture 2.6-fold as
compared to the GTPase reaction of 5 mM GIMAP7 alone (Fig-
ure 6A). This effect was not due to protein crowding because
addition of a 10-fold molar excess of GST to GIMAP7 did not
influence its hydrolytic activity.
To further investigate this effect, we performed a GTP protec-
tion assay using alkaline phosphatase. This enzyme readily
hydrolyzes GTP in solution to guanine, whereas it cannot hydro-
lyze nucleotides that are bound and therefore protected from
hydrolysis by a protein (John et al., 1990). In agreement with
the high affinity for GTP (Kd = 40 nM; Schwefel et al., 2010b),
GIMAP2 protected more than 40% of GTP from hydrolysis
by alkaline phosphatase over a period of 30 min, indicating
that GIMAP2 releases bound GTP very slowly (Figure 6A). This
is consistent with our observation that GIMAP2 expressed in
Figure 5. Dimerization-Dependent GTPase Activity of GIMAP7
Employs a Catalytic Arginine Finger
(A) 2FO-FC density, contoured at 1 s, is shown for Arg103 in chain B and the
watermolecule connecting the arginine side chain with the opposing GMPPNP
molecule via hydrogen bonding. Chain A is shown in green and chain B in cyan;
the P loop of chain A is colored in red. The magnesium ion is shown as a gray
sphere.
(B) Nucleotide-binding affinities of GIMAP7 mutants to GTP-g-S were deter-
mined using ITC, as in Figure 2A. The following values were obtained from the
fits: R103D (B), Kd = 14 ± 4 mM (n = 0.8); E136W (,), Kd = 19 ± 3 mM (n = 1.1).
(C) Sedimentation equilibrium ultracentrifugation experiments for GIMAP7
R103D (:) and E136W (,) in the presence of 200 mM GMPPNP, as in Fig-
ure 2B. The following values for a monomer-dimer equilibrium were obtained
from the data fits: GIMAP7 E136W: Kd = 47 ± 6 mM, GIMAP7 R103D: Kd = 8 ±
1 mM. Data for GIMAP7 (B, Figure 2B) in the presence of 200 mMGMPPNP are
shown for comparison.
(D) Nucleotide hydrolysis of the E136W (:) and R103D (,) mutants of
GIMAP7 were measured by HPLC in a single turnover assay (using a protein
and nucleotide concentration of 50 mM), as in Figure 2C. GTP hydrolysis of
GIMAP7 (B, Figure 2C) is shown for comparison. Data points are mean
values ± SD of three independent experiments.
Structure
GTPase Activation in the GIMAP Familybacteria retains GTP during the purification process (Schwefel
et al., 2010b). However, when GIMAP2 was combined with
5 mM GIMAP7, almost all of the GTP in the reaction mixture
was hydrolyzed within 30 min (Figure 6A). This suggests that
GIMAP7 can indeed stimulate GTP hydrolysis in GIMAP2.
The enhanced GTPase rate in GIMAP2/GIMAP7 mixtures was
further characterized using single site mutations in the G-inter-
face of both proteins. The GIMAP2 S54A mutation in switch I
prevents homodimerization (Schwefel et al., 2010b) and abro-
gated the increased GTPase rate in the GIMAP2-GIMAP7
mixture (Figure 6B), suggesting that stabilization of switch I in
GIMAP2 is also important for heterodimer formation. The
GIMAP2 R117D mutant, which cannot homodimerize (Schwefel
et al., 2010b), also did not show enhanced GTPase rates in our
assay (Figure 6B).
As shown in Figures 5C and 5D, the E136W mutation in
GIMAP7 impaired homodimerization and almost completely
eliminated the GTPase activity. Remarkably, when this mutant
was incubated with GIMAP2, efficient GTP hydrolysis wasStructure 21observed (Figure 6B). This strongly supports the existence of
a GIMAP2-GIMAP7 heterodimer whose architecture appears
to differ in detail from that of the GIMAP7 homodimer. The rate
enhancement effect was critically dependent on the presence
of the catalytic Arg103 in GIMAP7, since a mixture of GIMAP7
R103D and GIMAP2 showed no GTPase activity at all.
To further characterize the reaction, multiple turnover assays
(excess of GTP) were performed. Increasing concentrations
of GIMAP2 were titrated against a constant concentration
(2.5 mM) of GIMAP7 (Figure 6C). In these assays, the reaction
rate increased with increasing GIMAP2 concentration. The
concentration of GIMAP2 for half-maximal activation of overall
GTP hydrolysis was approximately 7 mM, which is in the range
of the homo-dimerization affinity of GIMAP7. This suggests
a low affinity interaction betweenGIMAP2 andGIMAP7. Addition
of increasing concentrations of the GIMAP2 R117D mutant to
GIMAP7 did not substantially affect the GTPase rate seen with
GIMAP7 alone (Figure 6C). Only very marginal GTPase activity
was observed for the GIMAP7 R103D mutant in the presence
of 50 mM GIMAP2, implying that GIMAP2 does not supply its
Arg117 as catalytic residue to complement the active site of GI-
MAP7 (Figure 6D).
Taken together, our data point to amechanismwhere GIMAP2
and GIMAP7 heterodimerize with low affinity in a transient
manner, and GIMAP7 acts as GTPase-activating protein for
GIMAP2 by supplying its catalytic arginine finger in trans.
Expression of GIMAPs in Anaplastic Large Cell
Lymphoma Cell Lines
GIMAP1, GIMAP4, and GIMAP5 are implicated in the regulation
of lymphocyte survival (Nitta et al., 2006; Schnell et al., 2006;
Schulteis et al., 2008; Barnes et al., 2010; Saunders et al.,
2010). Furthermore, GIMAPs have been identified as target
genes of NOTCH signaling (Chadwick et al., 2009; Wang et al.,
2011), a key pathway for malignant transformation of T lymphoid
cells. We therefore screened a panel of human T-cell leukemia
(Jurkat, KE-37, Molt-14, H9) and anaplastic large cell lymphoma
(ALCL) cell lines for alterations of GIMAP expression by semi-
quantitative reverse transcriptase (RT)-PCR analyses (Figure 7).
As a control, we included purified CD3+ and CD4+ T cells from
the peripheral blood of healthy donors. In the purified normal
CD3+ and CD4+ T cells, mRNA expression of all seven GIMAP
family members was detectable. Apart from a few exceptions
(e.g., GIMAP8 in KE-37 cells or GIMAP4 in Molt-14 cells), all
GIMAPs were expressed in the T cell leukemia-derived cell
lines investigated. In contrast, mRNA expression of various
GIMAPs was strongly reduced or even lost in most of the
ALCL-derived lymphoma cell lines (Figure 7). Interestingly,
whereas GIMAP2 mRNA was still present in all examined ALCL
cell lines, expression ofGIMAP7 and the closely relatedGIMAP4
was uniformly lost.
DISCUSSION
G proteins cycle between an active GTP-bound state and an
inactive GDP-bound state, and these states can be intercon-
verted by nucleotide exchange or GTP hydrolysis (reviewed in
Vetter and Wittinghofer, 2001). In G proteins of the Ras super-
family, GTP hydrolysis is stimulated by association with, 550–559, April 2, 2013 ª2013 Elsevier Ltd All rights reserved 555
Figure 6. GTPase Enhancement in Mixtures
of GIMAP2 and GIMAP7
(A) Nucleotide hydrolysis was measured by HPLC,
as in Figure 2C, employing 50 mM GIMAP2 (B),
5 mMGIMAP7 (6), and amixture of 50 mMGIMAP2
together with 5 mM GIMAP7 (,) at a GTP
concentration of 50 mM (complete nucleotide
loading of GIMAP2). Further control experiments
were conducted using mixtures of 50 mM GST
and 5 mM GIMAP7 (7) as well as 50 mM GIMAP2
and 0.2 U alkaline phosphatase (>, AP). This
amount of AP hydrolyzes 50 mM free GTP in less
than a minute (data not shown). Data points are
mean values ± SD of three independent experi-
ments. Note that under these conditions, GIMAP7
is not fully saturated with nucleotide, resulting in
a lower GTPase rate than in multiple turnover
assays.
(B) Mutational analysis of the GTPase rate
enhancement under single turnover conditions
for GIMAP2. Mixtures of 50 mM GIMAP2 and
5 mM GIMAP7 R103D (>), 50 mM GIMAP2, and
5 mM GIMAP7 E136W (7), 50 mM GIMAP2
R117D, and 5 mM GIMAP7 (B) as well as 50 mM
GIMAP2 S54A and 5 mM GIMAP7 (6) were
analyzed for their GTPase activities. The hydrolysis
reaction for 50 mM GIMAP2 together with 5 mM GIMAP7 (,) is shown for comparison (see Figure 6A). Data points are mean values ± SD of three independent
experiments.
(C) Analysis of the GTPase rate enhancement of GIMAP2/GIMAP2 R117D and GIMAP7 using multiple turnover conditions (500 mM GTP). A constant GIMAP7
concentration of 2.5 mM and increasing concentrations of GIMAP2 (B) or GIMAP2 R117D (,) were used. Rates were calculated by normalizing the reaction
velocity to the GIMAP7 concentration. Data points represent mean values ± range of two independent experiments.
(D) The GIMAP7 R103D mutant at a concentration of 2.5 mM is catalytically inactive and can be stimulated only to a minor extent by 50 mM GIMAP2. For
comparison, the GTPase activity of 2.5 mM GIMAP7 is shown (see Figure 6C). Data points represent mean values ± range of two independent experiments.
Structure
GTPase Activation in the GIMAP FamilyGTPase-activating proteins (GAPs)whichoften supply a catalytic
arginine residue in trans to complement the active site (Bos et al.,
2007). In a second class of G proteins, GTPase activity is trig-
gered by nucleotide-dependent dimerization of the G domains
(Gasper et al., 2009). These G proteins include members of the
dynamin superfamily (Praefcke and McMahon, 2004), septins
(Sirajuddin et al., 2007), and the septin-related Toc proteins
(Sun et al., 2002; Koenig et al., 2008). Dimerization in dynamins
induces rearrangements of catalytic residues in cis, thereby
inducing GTPase stimulation (e.g., Ghosh et al., 2006). In sep-
tins, a threonine residue in switch I is stabilized upon dimerization
and positions the catalytic water molecule in cis for GTPase acti-
vation (Sirajuddin et al., 2009). For Toc proteins, a conserved
arginine is in the vicinity of the nucleotide-binding cleft of the
opposing molecule, but its role in catalysis is disputed (Sun
et al., 2002; Koenig et al., 2008). Our results indicate that
GIMAPs also belong to the group of G proteins whose GTPase
activity is stimulated by dimerization. We show that a highly
conserved arginine from the conserved box motif in the GIMAP
G-interface has a dual function. In the GIMAP2 homodimer, it
stabilizes the dimerization interface as a mere structural residue.
In this way, further scaffold assembly via a second dimerization
interface may proceed (Schwefel et al., 2010b). By contrast, we
demonstrate here that the equivalent arginine residue in GIMAP7
acts as a catalytic arginine finger in the GIMAP7 homodimer
and GIMAP7-GIMAP2 heterodimer, by complementing the
active site of the opposing monomer. Thus, the conserved box
arginine serves a dual function by promoting self-association
and stimulating GTP hydrolysis. The observed colocalization of556 Structure 21, 550–559, April 2, 2013 ª2013 Elsevier Ltd All rightsGIMAP2 and GIMAP7 at lipid droplets and our biochemical
data demonstrating the specific ability of GIMAP7 to stimulate
GTP hydrolysis in GIMAP2 argue for a functional interplay of
these two GTPases in vivo.
Also in other GTPase families, interactions between members
of two functionally distinct subgroups have been shown to
modulate catalytic activity, for example in the immunity-related
GTPases (IRG) (Hunn et al., 2008). In contrast to our findings,
members of one IRG subgroup assemble with proteins of the
second subgroup to prevent GTP loading and activation. The
proposed catalytic mechanism, however, involves homodimeri-
zation (Pawlowski et al., 2011). Heterodimer formation and
subsequent GTPase activation is also observed in the signal
recognition particle (SRP) and its receptor (SRPR) (reviewed in
Grudnik et al., 2009). However, compared to the septin and
dynamin GTPases, the SRP-SRPR system appears to have
evolved independently (Schwefel et al., 2010b).
Taking into account the known biochemical and functional
characteristics of individual GIMAP family members, a pattern
emerges. GIMAP1, GIMAP2, and GIMAP5 appear to be
stably associated with specific cellular compartments by their
C-terminal hydrophobic sequences. GIMAP2 (Schwefel et al.,
2010b) and GIMAP5 (D.S. and O.D., unpublished data) bind
GTP with high affinity but cannot hydrolyze it on their own. Their
high local concentration at membrane surfaces and their
restricted mobility due to the C-terminal membrane anchors
might promote the formation of a GIMAP scaffold in the GTP-
bound form, despite their low dimerization affinity (Schwefel
and Daumke, 2011; Wu et al., 2011). In the GDP-boundreserved
Figure 7. Altered Expression of Human GIMAPs in ALCL-Derived
Lymphoma Cell Lines
mRNA expression of the seven human GIMAP family members was deter-
mined by semiquantitative RT-PCR in purified CD3+ and CD4+ T cells from the
peripheral blood of two healthy donors (#1, #2; primary T cells), a panel of T cell
leukemia cell lines (T cell lines) and a panel of eight ALCL-derived lymphoma
cell lines (ALCL). mRNA expression of GAPDH was analyzed as a control.
Structure
GTPase Activation in the GIMAP Familyform, these GIMAP scaffolds were proposed to disassemble
(Schwefel et al., 2010b).
In contrast, GIMAP7 binds guanine nucleotides with lower
affinity and catalyzes GTP hydrolysis by a dimerization-depen-
dent mechanism. Similarly, GTPase activity has been demon-
strated for the closely related GIMAP4 (Cambot et al., 2002).
Based on the results for GIMAP2 and GIMAP7, we propose
a scenario in which catalytically active GIMAP members stimu-
late GTP hydrolysis in the catalytically inactive GIMAPs. Such
a model could, for example, rationalize the proposed opposing
functions of GIMAP4 and GIMAP5 in lymphocyte survival
observed in animal models (e.g., Chen et al., 2011; Schnell
et al., 2006). In its GTP-bound form, a GIMAP5 scaffold can
form andmay inhibit apoptosis. GIMAP4may disrupt these scaf-
folds by heterodimerization with and stimulation of GTPase
activity in GIMAP5. Such a model is also consistent with our
GIMAP mRNA expression data in lymphoma cell lines, which
largely agrees with mRNA microarray analyses from primary
ALCL (Eckerle et al., 2009).GIMAP4 andGIMAP7 are completely
downregulated in ALCL cell lines compared to different T cell
lines, whereas GIMAP2 is present in the whole ALCL panel and
GIMAP5 in half of the ALCL lines.
In summary, our study provides the structural and biochemical
framework for examining the differential functions of GIMAPs in
lymphocyte survival, for elucidating the molecular details of
GIMAP interactions with their target proteins, and for identifying
the cellular pathways involving GIMAPs that might be altered in
human T cell lymphoma.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
GIMAP2 and its mutants were expressed and purified as described (Schwefel
et al., 2010a). GIMAP7 and mutants were expressed and purified in the
same way, with an additional wash step during affinity chromatography usingStructure 2150mMHEPES pH 7.5, 500mMNaCl, 2.5 mMDTT, 2 mMMgCl2, 0.1 mMGDP,
and 1%CHAPS. Protein at a concentration of about 30mg/ml was flash-frozen
in small aliquots in liquid nitrogen and stored at 80C. All GTPase experi-
ments within one figure panel were carried out with one batch of protein,
due to slight variations in the GTPase activity of different preparations and
loss of activity after extended storage (>24 hr) at 4C.
Crystallization and Data Collection
GMPPNP (Jena Bioscience) and MgCl2 were added to a final concentration of
2 mM. Crystallization trials were performed using the hanging-drop vapor-
diffusion method at 20C. One microliter of the protein solution at a GIMAP7
concentration of 10 mg/ml was mixed with an equal volume of reservoir
solution containing 19% PEG 3350 and 100 mMMOPS, pH 6.5. Crystal plates
with dimensions of 0.2 mm3 0.2 mm3 0.01 mm appeared after 1 day. Single
plates were separated and transferred to a cryosolution containing 10 mM
HEPES pH 7.5, 300 mM NaCl, 2.5 mM DTT, 2 mM MgCl2, 2 mM GMPPNP,
32% PEG 3350, 100 mM MOPS pH 6.5, and flash-cooled in liquid nitrogen.
A data set was collected on beamline 14.1 at BESSY and processed using
the XDS program suite (Kabsch, 1993).
Structure Analysis and Refinement
The structure of GIMAP7 was solved by molecular replacement using Molrep
(Vagin and Teplyakov, 1997) with GTP-bound GIMAP21–234 as a search model
(Protein Data Base code 2XTN). Model building and refinement were carried
out using the programs Coot (Emsley and Cowtan, 2004) and Phenix (Murshu-
dov et al., 1997). The final model of GIMAP7 contains six protein molecules in
the asymmetric unit encompassing residues 8–69, 73–170, 173–295 of chain
A; 7–227, 258–293 of chain B; 8–230, 263–293 of chain C; 9–51, 57–169,
173–193, 198–216, 273–299 of chain D; 7–236, 242–297 of chain E; and
8–68, 73–138, 141–227, 250–262, 266–291 of chain F. Of all residues,
97.4% are in the favored region of the Ramachandran plot and 0.33%
are outliers. All protein structure representations were prepared using PyMOL
(DeLano,W.L. The PyMol Molecular Graphics System. DeLano Scientific,
Palo Alto, CA, USA; http://www.pymol.org). Solvent-accessible interface
areas in each monomer buried during dimer formation were calculated using
the PISA server (Krissinel and Henrick, 2007). Rmsd values were calculated
using Coot.
Isothermal Titration Calorimetry
ITC experiments were performed on a VP-ITC (GE Healthcare, Mu¨nchen,
Germany) at 8C using a protein concentration of 50 mM and a nucleotide
concentration of 1 mM. Dissociation constants were calculated using the
vendor-supplied Origin software.
Sedimentation Equilibrium Analytical Ultracentrifugation
Molecular mass studies of GIMAP7 constructs in 10 mM HEPES pH 7.5,
150mMNaCl, 2mMMgCl2, 2.5mMDTT and the indicated nucleotide concen-
trations were performed in an XL-A type analytical ultracentrifuge (Beckman).
Experiments were carried out using six-channel cells with 12 mm optical path
length and the capacity to handle three solvent-solution pairs of about 70 ml
volume. Sedimentation equilibrium was reached after 2 hr of overspeed at
24,000 rpm followed by an equilibrium speed of 20,000 rpm for about 30 hr
at 10C. The radial absorbance in each compartment was recorded at three
different wavelengths between 270 and 290 nm depending on the concentra-
tion used in the experiments. Molecular mass determinations employed the
global fit of the three radial distributions using the programs POLYMOLE or
POLYMOLA (Behlke et al., 1997). Assuming a monomer-dimer equilibrium,
the molecular mass, M, can be treated approximately as a weight average
parameter (Mw). This value is a composite of the monomer molecular mass
(Mm) and that of the dimer (Md) and the partial concentrations of monomers,
cm, and dimers, cd.
Mw =
ðcm3Mm + cd3MdÞ
cm + cd
:
Therefore, the equilibrium constant, Kd, can be determined by
Kd =
c2m
cd
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Single turnover GTPase rates at the indicated protein concentrations were
determined in 20 mM HEPES pH 7.5, 150 mM NaCl, 2.5 mM DTT, 5 mM
KCl, and 5 mM MgCl2 at 20
C in the presence of 50 mM GTP using standard
HPLC detection. In short, 20 ml reactions were applied to a Ti-Series 1050
HPLC system (Hewlett-Packard), equipped with a reversed-phase ODS-2
Hypersil column (Thermo Scientific). The running buffer contained 10 mM
Tetra-n-butylammonium bromide, 100 mM potassium phosphate (pH 6.5),
and 7.5% acetonitrile. Denatured proteins were adsorbed on a Nucleosil 100
C18 guard column (Knauer), and separated nucleotides were detected by
measuring the absorption at 254 nm.
For multiple turnover assays, a saturating GTP concentration of 500 mMwas
used. Rates derived from a linear fit to the initial reaction rates (<40% GTP
hydrolyzed) were plotted against the protein concentrations. For determination
of the apparent Kd and kmax, a simple binding model was fitted to the data that
describes the interaction of two GTP-bound GIMAP7 molecules inducing GTP
hydrolysis (Praefcke et al., 1999).
Cell Culture
Human ALCL cell lines (t[2;5]-positive: K299, SU-DHL-1, DEL, JB6; t[2;5]-
negative: FE-PD,Mac-1, Mac-2A, DL-40) and T cell leukemia-derived cell lines
(Jurkat, KE-37, Molt-14 and H9) were cultured as described (Mathas et al.,
2006). CD3+ and CD4+ peripheral T cells were purified from blood of healthy
donors using CD3 or CD4 MicroBeads (Miltenyi Biotec, Germany). The purity
of CD3+ and CD4+ T cells was greater than 97%, as determined by staining of
purified cells with a PE-conjugated anti-CD3 (Dako Deutschland GmbH) or
anti-CD4 antibody (BD Biosciences) and subsequent fluorescence-activated
cell sorter (FACS) analysis using a FACSCalibur flow cytometer (Becton Dick-
inson, Germany). The use of the human material was approved by the Local
Ethical Committee of the Charite´, Medical University Berlin, and performed
in accordance with the Declaration of Helsinki.
RNA Preparation and RT-PCR Analysis
Total RNA was prepared using the RNeasy kit (QIAGEN). For RT-PCR
analyses, first-strand cDNA synthesis was performed by use of the first-strand
cDNA synthesis kit (Roche, Germany) adding oligo-p(dT)15 primer according
to the manufacturer’s recommendation. See Supplemental Experimental
Procedures for primer sequences. All PCR products were verified by
sequencing.
Microscopy
For live cell microscopy, 5 3 106 cells were washed with PBS, centrifuged at
1,500 g for 5 min, and resuspended in 0.5 ml OPTIMEM medium (Invitrogen).
Cells were electroporated with 30 mg of plasmid DNA coding for mCherry or
EGFP fused N-terminally to the indicated construct in a BioRad Gene Pulser
(exponential protocol, V = 300 V, C = 500 mF). Forty-eight hours later, cells
were washed with PBS and stained with BODIPY 493/503 according to
(Gocze and Freeman, 1994). After two more washing steps with PBS, cells
were resuspended in 25 ml RPMI medium, and live cells were imaged using
Zeiss LSM 510 or Olympus FV1000 confocal microscopes (BODIPY: lexc =
488 nm, lem = BP505–530). Immunofluorescence procedures can be found
in the Supplemental Experimental Procedures.
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